Trexquant Investment LP

Position in BMY — Bristol Myers Squibb Co

CIK 1633445 STAMFORD, CT

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,456,248

-$16,520,268 QoQ

Shares Held

164,114

-61.7% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#402

of 2,506 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $226,269,634 across 5 Drug Manufacturers - General names. BMY ranks #4 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	90,850	$108,968,224
2	NVO	Novo Nordisk A S	1,227,405	$58,841,795
3	JNJ	Johnson & Johnson	191,502	$48,635,762
4	BMY	Bristol Myers Squibb Co This page	164,114	$9,456,248
5	PFE	Pfizer Inc	15,266	$367,605

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,456,248	164,114	-61.7%	Shares	Sole	2026-08-14
2026-03-31	$25,976,516	428,302	-46.9%	Shares	Sole	2026-05-15
2025-12-31	$43,515,285	806,735	-20.6%	Shares	Sole	2026-02-17
2025-09-30	$45,795,757	1,015,427	+437.9%	Shares	Sole	2025-11-14
2025-06-30	$8,738,024	188,767	+300.7%	Shares	Sole	2025-08-12
2024-09-30	$2,437,678	47,114	-69.6%	Shares	Sole	2024-11-12
2023-09-30	$8,992,891	154,943	-58.9%	Shares	Sole	2023-11-13
2023-06-30	$24,129,741	377,322	+320.4%	Shares	Sole	2023-08-11
2022-12-31	$6,457,224	89,746	+660.6%	Shares	Sole	2023-02-13
2022-06-30	$908,523	11,799	-78.3%	Shares	Sole	2022-08-11
2021-09-30	$3,216,836	54,366	+1471.3%	Shares	Sole	2021-11-12
2021-06-30	$231,197	3,460	-94.2%	Shares	Sole	2021-08-12
2020-12-31	$3,675,401	59,252	-34.4%	Shares	Sole	2021-02-11
2020-09-30	$5,447,563	90,356	+235.9%	Shares	Sole	2020-11-06
2020-06-30	$1,581,720	26,900	—	Shares	Sole	2020-08-07
No filing history on record for this holder in this stock.